# Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

> **NCT05446376** · PHASE2 · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 40 (estimated)

## Conditions studied

- Infective Endocarditis

## Interventions

- **DRUG:** 68Ga-citrate PET/CT

## Key facts

- **NCT ID:** NCT05446376
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-22
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05446376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05446376, "Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05446376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
